Axonia Medical is pioneering a revolutionary and proprietary approach to repair and restore damaged peripheral or central nervous systems using tissue-engineered nerve grafts (TENGs). By recapitulating the anatomy of the nervous system, TENGs are expected to bridge lost nervous tissue and jump-start regenerative mechanisms to achieve levels of functional recovery not possible with current technologies.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/10/12 | $2,000,000 | Seed |
Ann Arbor SPARK Biosciences Research and Commercialization Center Southwest Michigan First Life Science Venture Fund Western Michigan University Research Foundation | undisclosed |
